In 2011, A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma.Tumors were induced in nude mice

BACKGROUND: The present work was therefore undertaken to study the potential synergic antitumoral action of TMZ (the benchmark agent for the management of GBM) and THC and CBD. Mice were assigned randomly to various groups and injected peritumorally for 14 days with the different treatments

You can read the full article here => http://mct.aacrjournals.org/content/10/1/90